Skip to main content

CalbaTech Acquires MolecularWare

NEW YORK, June 9 - Biotech incubator CalbaTech said today that it has agreed to acquire privately held bioinformatics firm MolecularWare.


Financial terms of the acquisition were not disclosed.


CalbaTech said that MolecularWare, which markets a suite of software tools called DigitalGenome, was a key acquisition target because it "validates CalbaTech's business model in which it is seeking to acquire life-sciences-based companies that have near-term revenue or already have revenue and need a modest infusion of capital and a new structure."


CalbaTech's mission is to incubate companies that will generate sales or licensing revenues within two years and that require less than $1 million to bring a product to market. To date, the company has completed two other technology acquisition agreements: A license to slide-based diagnostics technology from Scottish diagnostics firm QICC; and a DNA isolation and extraction technology developed by J. Zoval, an associate inventor with CalbaTech.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.